Press Releases

INCLINE VILLAGE, Nev., March 12, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the March 12, 2013 , regular quarterly dividend payment of $0.15 per share to all stockholders owning shares of PDL as of March 5, 2013 , the record date.

INCLINE VILLAGE, Nev. , March 11, 2013 /PRNewswire/ --  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced royalty revenue guidance for the first quarter ending March 31, 2013 , of approximately $92 million , as compared with actual royalty revenue of $77 million for the first quarter of

INCLINE VILLAGE, Nev. , March 6, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the company will hold its annual meeting of stockholders on Tuesday, May 21, 2013 , at 10:00 a.m. Pacific Time for all stockholders of record on March 28, 2013 .

INCLINE VILLAGE, Nev. , March 4, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for the: 2.875% Convertible Senior Notes due February 15, 2015 ( February 2015 Notes) is 173.200 shares of common stock per $1,000 principal amount or

INCLINE VILLAGE, Nev. , March 1, 2013 /PRNewswire/ --  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the fourth quarter and full year ended December 31, 2012 . (Logo:  http://photos.prnewswire.com/prnh/20110822/SF55808LOGO ) Total revenues in 2012 were $374.5 million

INCLINE VILLAGE, Nev. , Feb. 25, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its fourth quarter and full year 2012 financial results for the period ended December 31, 2012 , on Friday, March 1, 2013 , after market close.

INCLINE VILLAGE, Nev. , Feb. 20, 2013   /PRNewswire/ --   PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin , the company's president and chief executive officer, will present at the following upcoming conferences. RBC Capital Markets Healthcare Conference Wednesday,

-- Dividend Amount of $0.15 per Share per Quarter --

INCLINE VILLAGE, Nev. , Jan. 30, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that Caroline Krumel resigned her position as vice president of finance and principal accounting officer effective immediately on January 25th . Ms.

INCLINE VILLAGE, Nev. , Jan. 3, 2013 /PRNewswire/ --   PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin , the company's president and chief executive officer, is scheduled to present at the 31st Annual JP Morgan Healthcare Conference in San Francisco on Thursday,

INCLINE VILLAGE, Nev. , Dec. 17, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the December 14, 2012 , regular quarterly dividend payment of $0.15 per share to all stockholders owning shares of PDL as of December 7, 2012 , the record date.

INCLINE VILLAGE, Nev. , Dec. 6, 2012 /PRNewswire/ --   PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced royalty revenue guidance for the fourth quarter ending December 31, 2012 , of approximately $86 million , as compared with actual royalty revenue of $73 million for the fourth quarter of

INCLINE VILLAGE, Nev. , Dec. 5, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for the: 2.875% Convertible Senior Notes due February 15, 2015 ( February 2015 Notes) is 169.525 shares of common stock per $1,000 principal amount or

INCLINE VILLAGE, Nev. , Dec. 3, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that Bruce Tomlinson has resigned his position as vice president and chief financial officer of PDL due to personal reasons.  His resignation is effective as of November 30 , 2012.  The

INCLINE VILLAGE, Nev. , Nov. 8, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin , the company's president and chief executive officer, is scheduled to present at the Lazard Capital Markets 9 th Annual Healthcare Conference on Tuesday, November